News Releases

10 Feb '20
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 10, 2020-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases, today announced that it has closed its private
05 Feb '20
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 5, 2020-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases, today announced that it has entered into stock
Displaying 21 - 25 of 25